Amniotic epithelial cells from the human placenta potently suppress a mouse model of multiple sclerosis

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Liu, Yu Han ^a   Vaghjiani, Vijesh ^a   Tee, Jing Yang ^a   To, Kelly ^a   Cui, Peng ^a   Oh, Ding Yuan ^a   Manuelpillai, Ursula ^a   Toh, Ban Hock ^a   Chan, James ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN; INTERLEUKIN 5; NEUTRALIZING ANTIBODY; PROSTAGLANDIN E2; TRANSFORMING GROWTH FACTOR BETA; CYTOKINE;

AMNION CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD3+ T LYMPHOCYTE; CELL INFILTRATION; CELL PROLIFERATION; CELL THERAPY; CELL TRACKING; CELL TRANSPLANTATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; EPITHELIUM CELL; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PLACENTA; SPLEEN CELL; TH2 CELL; AMNION; ANIMAL; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DISEASE MODEL; DRUG EFFECT; IMMUNOLOGY; METABOLISM; PATHOLOGY; PREGNANCY; SPINAL CORD; SPLEEN;

MUS;

AMNION; ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; DINOPROSTONE; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOSUPPRESSION; INTERLEUKIN-5; MICE; MICE, INBRED C57BL; MULTIPLE SCLEROSIS; PLACENTA; PREGNANCY; SPINAL CORD; SPLEEN; TH2 CELLS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84860368673     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035758     Document Type: Article

References (46)

1. Hafler DA, Slavik JM, Anderson DE, O'Connor KC, De Jager P, et al. (2005) Multiple sclerosis. Immunol Rev 204: 208-231.
2. Stinissen P, Raus J, Zhang J, (1997) Autoimmune pathogenesis of multiple sclerosis: role of autoreactive T lymphocytes and new immunotherapeutic strategies. Crit Rev Immunol 17: 33-75.
3. Clements CS, Reid HH, Beddoe T, Tynan FE, Perugini MA, et al. (2003) The crystal structure of myelin oligodendrocyte glycoprotein, a key autoantigen in multiple sclerosis. Proc Natl Acad Sci U S A 100: 11059-11064.
4. von Budingen HC, Tanuma N, Villoslada P, Ouallet JC, Hauser SL, et al. (2001) Immune responses against the myelin/oligodendrocyte glycoprotein in experimental autoimmune demyelination. J Clin Immunol 21: 155-170.
5. Slavin A, Ewing C, Liu J, Ichikawa M, Slavin J, et al. (1998) Induction of a multiple sclerosis-like disease in mice with an immunodominant epitope of myelin oligodendrocyte glycoprotein. Autoimmunity 28: 109-120.
6. Chan J, Ban EJ, Chun KH, Wang S, Backstrom BT, et al. (2008) Transplantation of bone marrow transduced to express self-antigen establishes deletional tolerance and permanently remits autoimmune disease. J Immunol 181: 7571-7580.
7. Chan J, Ban EJ, Chun KH, Wang S, McQualter JL, et al. (2008) Methylprednisolone induces reversible clinical and pathological remission and loss of lymphocyte reactivity to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis. Autoimmunity 41: 405-413.
8. Uccelli A, Laroni A, Freedman MS, (2011) Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases. Lancet Neurol 10: 649-656.
9. Gang EJ, Bosnakovski D, Figueiredo CA, Visser JW, Perlingeiro RC, (2007) SSEA-4 identifies mesenchymal stem cells from bone marrow. Blood 109: 1743-1751.
10. Ilancheran S, Michalska A, Peh G, Wallace EM, Pera M, et al. (2007) Stem cells derived from human fetal membranes display multilineage differentiation potential. Biol Reprod 77: 577-588.
11. Miki T, Lehmann T, Cai H, Stolz DB, Strom SC, (2005) Stem cell characteristics of amniotic epithelial cells. Stem Cells 23: 1549-1559.
12. Parolini O, Alviano F, Bagnara GP, Bilic G, Buhring HJ, et al. (2008) Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cells 26: 300-311.
13. Bailo M, Soncini M, Vertua E, Signoroni PB, Sanzone S, et al. (2004) Engraftment potential of human amnion and chorion cells derived from term placenta. Transplantation 78: 1439-1448.
14. Wolbank S, Peterbauer A, Fahrner M, Hennerbichler S, van Griensven M, et al. (2007) Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: a comparison with human mesenchymal stem cells from adipose tissue. Tissue Eng 13: 1173-1183.
15. Li H, Niederkorn JY, Neelam S, Mayhew E, Word RA, et al. (2005) Immunosuppressive factors secreted by human amniotic epithelial cells. Invest Ophthalmol Vis Sci 46: 900-907.
16. Uchida S, Inanaga Y, Kobayashi M, Hurukawa S, Araie M, et al. (2000) Neurotrophic function of conditioned medium from human amniotic epithelial cells. J Neurosci Res 62: 585-590.
17. Uchida S, Suzuki Y, Araie M, Kashiwagi K, Otori Y, et al. (2003) Factors secreted by human amniotic epithelial cells promote the survival of rat retinal ganglion cells. Neurosci Lett 341: 1-4.
18. Miki T, Marongiu F, Ellis E, S CS, (2007) Isolation of amniotic epithelial stem cells. Curr Protoc Stem Cell Biol Chapter 1: Unit 1E 3.
19. Pratama G, Vaghjiani V, Tee JY, Liu YH, Chan J, et al. (2011) Changes in culture expanded human amniotic epithelial cells: implications for potential therapeutic applications. PLoS ONE 6: e26136.
20. Manuelpillai U, Tchongue J, Lourensz D, Vaghjiani V, Samuel CS, et al. (2010) Transplantation of human amnion epithelial cells reduces hepatic fibrosis in immunocompetent CCl-treated mice. Cell Transplant 19: 1157-1168.
21. Chen XT, Chan ST, Hosseini H, Layton D, Boyd R, et al. (2011) Transplantation of retrovirally transduced bone marrow prevents autoimmune disease in aged mice by peripheral tolerance mechanisms. Autoimmunity 44: 384-393.
22. Ajami B, Bennett JL, Krieger C, McNagny KM, Rossi FM, (2011) Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool. Nat Neurosci 14: 1142-1149.
23. Sakaguchi S, Miyara M, Costantino CM, Hafler DA, (2010) FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol 10: 490-500.
24. Wing K, Sakaguchi S, (2010) Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat Immunol 11: 7-13.
25. Workman CJ, Szymczak-Workman AL, Collison LW, Pillai MR, Vignali DA, (2009) The development and function of regulatory T cells. Cell Mol Life Sci 66: 2603-2622.
26. Moodley Y, Ilancheran S, Samuel C, Vaghjiani V, Atienza D, et al. (2010) Human amnion epithelial cell transplantation abrogates lung fibrosis and augments repair. Am J Respir Crit Care Med 182: 643-651.
27. Kong XY, Cai Z, Pan L, Zhang L, Shu J, et al. (2008) Transplantation of human amniotic cells exerts neuroprotection in MPTP-induced Parkinson disease mice. Brain Res 1205: 108-115.
28. Kehrl JH, Wakefield LM, Roberts AB, Jakowlew S, Alvarez-Mon M, et al. (1986) Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 163: 1037-1050.
29. McKarns SC, Kaminski NE, (2000) TGF-beta 1 differentially regulates IL-2 expression and [3H]-thymidine incorporation in CD3 epsilon mAb- and CD28 mAb-activated splenocytes and thymocytes. Immunopharmacology 48: 101-115.
30. Shalaby MR, Ammann AJ, (1988) Suppression of immune cell function in vitro by recombinant human transforming growth factor-beta. Cell Immunol 112: 343-350.
31. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, et al. (1992) Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359: 693-699.
32. Li MO, Sanjabi S, Flavell RA, (2006) Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and-independent mechanisms. Immunity 25: 455-471.
33. Laouar Y, Town T, Jeng D, Tran E, Wan Y, et al. (2008) TGF-beta signaling in dendritic cells is a prerequisite for the control of autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 105: 10865-10870.
34. Racke MK, Cannella B, Albert P, Sporn M, Raine CS, et al. (1992) Evidence of endogenous regulatory function of transforming growth factor-beta 1 in experimental allergic encephalomyelitis. Int Immunol 4: 615-620.
35. Racke MK, Dhib-Jalbut S, Cannella B, Albert PS, Raine CS, et al. (1991) Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1. J Immunol 146: 3012-3017.
36. Harris SG, Padilla J, Koumas L, Ray D, Phipps RP, (2002) Prostaglandins as modulators of immunity. Trends Immunol 23: 144-150.
37. Woolard MD, Wilson JE, Hensley LL, Jania LA, Kawula TH, et al. (2007) Francisella tularensis-infected macrophages release prostaglandin E2 that blocks T cell proliferation and promotes a Th2-like response. J Immunol 178: 2065-2074.
38. Li H, Nourbakhsh B, Safavi F, Li K, Xu H, et al. (2011) Kit (W-sh) mice develop earlier and more severe experimental autoimmune encephalomyelitis due to absence of immune suppression. J Immunol 187: 274-282.
39. Zhang GX, Yu S, Gran B, Rostami A, (2005) Glucosamine abrogates the acute phase of experimental autoimmune encephalomyelitis by induction of Th2 response. J Immunol 175: 7202-7208.
40. Engelhardt B, (2006) Molecular mechanisms involved in T cell migration across the blood-brain barrier. J Neural Transm 113: 477-485.
41. Zamvil SS, Steinman L, (1990) The T lymphocyte in experimental allergic encephalomyelitis. Annu Rev Immunol 8: 579-621.
42. Hickey WF, Hsu BL, Kimura H, (1991) T-lymphocyte entry into the central nervous system. J Neurosci Res 28: 254-260.
43. Swanborg RH, (1995) Experimental autoimmune encephalomyelitis in rodents as a model for human demyelinating disease. Clin Immunol Immunopathol 77: 4-13.
44. Benveniste EN, (1997) Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis. J Mol Med (Berl) 75: 165-173.
45. Prockop DJ, Youn Oh J, (2011) Mesenchymal Stem/Stromal Cells (MSCs): Role as Guardians of Inflammation. Mol Ther.
46. Roddy GW, Oh JY, Lee RH, Bartosh TJ, Ylostalo J, et al. (2011) Action at a Distance: Systemically Administered Adult Stem/Progenitor Cells (MSCs) Reduce Inflammatory Damage to the Cornea Without Engraftment and Primarily by Secretion of TNF-alpha Stimulated Gene/Protein 6. Stem Cells 29: 1572-1579.